![]() |
|
|
Vol. 281, Issue 1, 9-14, 1997
Centre for Clinical Pharmacology, The Cruciform Project, The Rayne Institute, University College London, London, United Kingdom
| |
Abstract |
|---|
|
|
|---|
Sensory C-fibers have been implicated in the control of vascular tone
and are believed to be predominantly arteriolar in the microvasculature. There have been no direct investigations into the
effects of C-fiber activation in venous microvessels. Therefore, we
have investigated the effects of neuropeptides and activation of
sensory C-fibers in rat small mesenteric veins. Small second- or
third-order veins were dissected from the rat mesentery and mounted in
a tension myograph for measurement of reactivity. Neither substance P
or calcitonin gene-related peptide (CGRP) relaxed precontracted veins.
However, substance P caused a concentration-dependent contraction. The
curve was shifted to the right in a concentration-dependent manner by
the tachykinin neurokinin1 receptor antagonist RP 67,580 (0.1-1 µM). To activate sensory C-fibers, capsaicin was applied. Capsaicin had no contractile activity in these vessels but caused concentration-dependent relaxation. This response was significantly attenuated in veins taken from animals in which C-fibers had been largely destroyed (P < .001, n = 5) and in
vessels that had been pretreated with the vanilloid receptor blocker
ruthenium red (P < .01, n = 5). Endothelial
denudation (n = 6) also abolished the response, but
the nitric oxide synthase inhibitor
NG-monomethyl-L-arginine (100 µM, n = 5) did not inhibit the response; N
-nitro-L-arginine methyl
ester (100-300 µM, n = 4) did inhibit the
response. The guanylyl cyclase inhibitor
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one also significantly
attenuated the response (n = 5). The cyclooxygenase inhibitor indomethacin (5 µM, n = 5) and the CGRP
receptor antagonist CGRP8-37 (1 µM) were without effect.
These results demonstrate that capsaicin, a selective C-fiber
activator, relaxes small veins in an endothelium-dependent but CGRP-
and substance P-independent manner, and they demonstrate that the
venous side of the microcirculation responds directly to sensory
stimulation.
| |
Introduction |
|---|
|
|
|---|
Sensory nerves are involved in
the control of vascular tone and appear to play an important role in
certain types of vascular inflammation. The proinflammatory nature of
neuropeptides released from sensory C-fibers has been demonstrated in
several models of inflammation, and neurogenic components have been
identified in inflammatory disease states, including rheumatoid
arthritis (Levine et al., 1985
) and asthma (Barnes, 1986
).
Activation of sensory C-fibers may be achieved in several ways,
including application of the agent capsaicin, the active ingredient of
`chili pepper' (Jancso et al., 1967
), which selectively
activates sensory C-fibers (for reviews, see Holzer, 1991
; Dray, 1992
), or direct electrical stimulation of nerve fibers. C-fibers are located
within the arteriolar side of the microcirculation (e.g., Fleming et al., 1989
; Baluk et al., 1992
), and
activation of these nerves results in the release of the neuropeptides
CGRP and SP (Holzer, 1991
). It is generally assumed that C-fibers do
not innervate the venous side of the microcirculation (e.g.,
McDonald, 1988
; Baluk et al., 1992
). Indeed, although there
are studies demonstrating the innervation of larger veins, such as
human saphenous vein (Herbst et al., 1992
), there is no
immunohistochemical evidence demonstrating SP or CGRP immunoreactivity
in the walls of small veins. When arteriolar C-fibers are activated,
CGRP is thought to act at the arteriolar level to produce
vasodilatation, whereas SP travels downstream to increase venular
permeability. Together, these effects produce greater net edema than
does either alone. This synergism has been attributed to an increase in
the hydrostatic pressure (due to selective arteriolar dilatation),
coupled with increased movement of fluid out of the permeable venules.
Synergism between CGRP and SP has been demonstrated in the skin of
rabbits and rats (Brain and Williams, 1985
; Gamse and Saria, 1985
).
However, this has not been a universal finding, and other studies have
demonstrated that CGRP has an inhibitory effect (Raud et
al., 1991
) or no effect (Ekblom et al., 1993
) on the
response to agents that increase venular permeability. These studies
have all relied upon exploring the effects of the neuropeptides
in vivo or in intact perfused vascular beds in
vitro. In these integrated experimental systems, it is difficult
to distinguish between direct effects of neurogenic stimulation on the
component parts of the vasculature. To overcome this problem, we have
undertaken studies of isolated microvessels in vitro. We
previously demonstrated that C-fiber activation in small arteries
relaxes constricted vessels and inhibits the contractile responses to
sympathetic stimulation (Ahluwalia and Vallance, 1996a
). We have now
investigated the effects of neuropeptides and capsaicin on the
reactivity of isolated small veins of the microcirculation of the rat
mesentery. These results have been presented in preliminary form to The
British Pharmacological Society (Ahluwalia and Vallance, 1996b
).
| |
Methods |
|---|
|
|
|---|
Preparation of vessels.
Male Wistar rats (240-280 g) were
stunned and the neck dislocated. The mesentery was removed and placed
in oxygenated cold (4°C) Krebs solution (composition, in mM: NaCl,
118; KCl, 4.69; CaCl2, 2.5; KH2PO4,
1.18; MgSO4, 1.18; NaHCO3, 25; glucose, 11). Small second- or third-order veins were dissected out and mounted in
cold Krebs' solution as ring preparations suspended between two
stainless steel wires of 40-µm diameter, in an automated myograph (JP
Trading, Aarhus, Denmark), for the measurement of isometric tension
(Mulvany and Halpern, 1977
). After vessels were mounted, the
temperature of the bath was raised to 37°C and the Krebs solution was
bubbled with 5% CO2 in O2 (pH after bubbling,
7.4). After a 45-min equilibration period, vessels were stretched in a
stepwise manner to determine the relationship between the passive
tension and the internal circumference, according to Laplace's
equation. They were then stretched to 90% of the diameter achieved
when the vessel was under a transmural pressure of 20 mm Hg
(i.e., the pressure approximating conditions in
vivo). Vessels were repeatedly constricted with the thromboxane
A2-mimetic U-46619 (0.1 µM), until the response was
constant, before experimentation. Integrity of the endothelium was
determined by assessing the relaxation response to bradykinin (1 µM)
in vessels submaximally precontracted with U-46619 (10-100 nM). In
experiments where removal of the endothelium was required, a hair was
passed through the lumen of the vessels before measurement of the
bradykinin response. Endothelium was considered removed when responses
to bradykinin were <10% relaxation.
Effects of exogenous neuropeptides. The effects of CGRP (0.1-10 nM) and SP (1-10,000 nM) were determined under conditions of basal tone and in preparations in which stable tone had been induced with U-46619 (10-100 nM). In unprecontracted vessels, contractile concentration-response curves for SP were repeated until constant, with a 45-min washing period between each curve. When the curves were constant, tissues were incubated with the NK1 receptor antagonist RP 67,580 (0.1-1 µM, 30-min pretreatment), the inactive enantiomer RP 68,651 (1 µM) or the NK2 receptor blocker SR 48968 (1 µM, 2-hr pretreatment). At the end of each experiment the maximal contraction in response to U-46619 (1 µM) was determined.
Responses to capsaicin. Effects of capsaicin were determined under conditions of basal tone and in preparations in which tone had been induced with U-46619 (10-100 nM). In precontracted preparations, a single relaxation concentration-response curve for capsaicin (1-30 µM) was constructed.
In some animals C-fibers were removed chemically before experimentation, by systemic treatment with capsaicin (50 mg/kg) or by s.c administration of capsaicin once 4 days before use. Veins from these animals (or vehicle-treated controls) were removed, and the response to capsaicin was measured. This systemic treatment with capsaicin results in approximately 90% selective destruction of C-fibers in adult rats (Gamse, 1982Materials.
Capsaicin, ruthenium red, SP, indomethacin,
L-NAME and U-46619 were purchased from Sigma Chemical Co.
(Poole, UK), and CGRP and CGRP8-37 were purchased from
Bachem (Saffron Walden, UK). L-NMMA and ODQ were kind gifts
of Dr. Salvador Moncada of Wellcome Research Laboratories (Kent, UK).
RP 67,580 and RP 68,651 were kind gifts of Dr. C. Garret of Rhône
Poulenc Rorer (Vitry sur Seine, France) and SR 48968 of Dr. X. Emonds-Alt of Sanofi Recherche (Montpellier, France). Solutions of
ruthenium red and L-NMMA were prepared in distilled water
on the day of use. Indomethacin was dissolved in 1% sodium carbonate
in water on the day of use. Stock solutions were made as follows:
U-46619 in ethanol, CGRP, CGRP8-37 and SP in distilled
water, capsaicin in ethanol and ODQ in dimethylsulfoxide. The final
concentration of ethanol in the myograph bathing solution was <0.5%.
All stock solutions were kept at
20°C until required. Dilutions
were made in Krebs solution.
Data and statistics. For measurement of the effects of antagonists on the concentration-response curve for SP, the EC50 for SP was determined for each experiment in control and antagonist-treated vessels and the shift was expressed as a concentration ratio of the EC50 for SP (control) and the EC50 for SP in the presence of antagonist. For capsaicin concentration-response curves, a maximum plateau response was not reached. To assess shifts in concentration-response curves, the concentration of capsaicin required to produce an equivalent relaxation (usually 50% of the maximum response achieved with 30 µM capsaicin in control studies) was calculated as a concentration ratio. Statistical significance was calculated using analysis of variance for multiple comparisons, followed by the Bonferroni test. When multiple comparisons were not required, an unpaired Students t test was used. P < .05 was considered statistically significant.
| |
Results |
|---|
|
|
|---|
The mean diameter of veins used in the present study was 230 ± 13.2 µm (n = 48).
Effects of exogenous neuropeptides.
SP (1-1000 nM) caused a
concentration-dependent contraction of unprecontracted veins (see fig.
1 for typical contractile response curve). The
concentration-response curve was shifted to the right, in a
concentration-dependent manner, by the NK1 receptor
antagonist RP 67,580 (0.1, 0.3 and 1 µM, n = 5 for
each concentration), to give concentration ratios of 1.6 ± 0.3 and 3.0 ± 0.7 with 0.1 and 0.3 µM, respectively; with 1 µM a
maximum was not reached in all experiments, but a range of 5.0 to >100
µM was achieved. The EC50 for SP in these studies was
1.1 ± 0.2 µM (n = 15). The inactive enantiomer
RP 68,651 (1 µM) had no effect on the response to SP
(n = 4, not significant, data not shown), nor did
NK2 receptor blockade with SR 48,968 (1 µM,
n = 4, data not shown). CGRP had no effect in
unprecontracted veins, and neither CGRP (0.1-10 nM, n = 3) nor SP (0.1-1 µM, n = 3) had any relaxant
effects on vessels submaximally precontracted with U-46619 (10-100
nM). Pretreatment with CGRP (10 nM) did not alter the response to SP
(1-1000 nM, n = 3).
|
Effects of capsaicin.
Capsaicin had no effect on
unprecontracted vessels but caused a concentration-dependent relaxation
of precontracted vessels (fig. 2). The responses to
capsaicin were significantly (P < .001) attenuated in animals
denervated of C-fibers by pretreatment with capsaicin
(n = 5) (fig. 3), compared with the
responses in animals that had been treated with vehicle only
(n = 5). The responses to bradykinin (to check for
intact endothelium) were not significantly different in the two groups.
|
|
|
|
| |
Discussion |
|---|
|
|
|---|
This study demonstrates that local activation of C-fibers with capsaicin relaxes small mesenteric veins. This effect was endothelium-dependent but was not mediated by SP or CGRP and did not involve generation of prostanoid but did appear to involve NO. These results are the first direct demonstration of functional responses to sensory stimulation in the venous microcirculation.
Capsaicin, in concentrations similar to those that affect arterioles
and small arteries, caused a concentration-dependent relaxation of
precontracted small veins. This effect was markedly attenuated in veins
taken from animals in which C-fibers had been largely destroyed by
systemic capsaicin treatment (Gamse, 1982
; Maggi et al.,
1988
), suggesting that the relaxant effect seen in vitro was
due to C-fiber activation. This suggestion is further supported by the
finding that the concentration-response curve for capsaicin was shifted
to the right by ruthenium red, an agent that blocks the cation channel
associated with vanilloid receptors (Dray et al., 1990
), the
receptor/binding site for capsaicin on sensory nerves (Winter et
al., 1990
; Szallasi and Blumberg, 1990
). The finding that small
veins respond to capsaicin in the same manner as do small arteries
(Ahluwalia and Vallance, 1996a
) suggests that both vessel types possess
functionally active sensory C-fibers that respond to the same stimuli.
CGRP is released upon activation of arterial C-fibers and appears in
the venous effluent of perfused beds stimulated by capsaicin or
electrical field stimulation (Manzini et al., 1991
).
However, in the vessels we studied, CGRP had no effect on venous tone
and therefore is unlikely to contribute to the capsaicin response. Our
finding in isolated veins is similar to results from studies in the
perfused mesentery, demonstrating that CGRP has no effect on the
reactivity of the venous side of the mesenteric microcirculation (Claing et al., 1992
). Similarly, studies in humans have
demonstrated that CGRP does not dilate capacitance vessels of the hand
(Marshall et al., 1988
) or human saphenous vein (McEwan
et al., 1988
). In contrast, a recent study using intravital
microscopy of the rat cremaster muscle demonstrated that capsaicin,
applied topically, dilates arterioles and venules (Kim et
al., 1995
) and that the response is blocked by the CGRP receptor
antagonist CGRP8-37. The differences between our study and
this earlier study might be due to differences between vascular beds.
However, it is possible that the capsaicin-induced and CGRP-dependent
venodilatation seen in the in situ cremaster muscle
preparation is due to an effect of a mediator released from the
arterial side of the circulation in response to CGRP, rather than a
direct effect of CGRP on the veins themselves.
The relaxant effects of capsaicin we observed are unlikely to be due to
SP. SP had no effect on the precontracted preparations but caused
reproducible concentration-dependent contractions in uncontracted
veins. This response was mediated by the activation of NK1
receptors, because the selective nonpeptide NK1 receptor antagonist RP 67,580 antagonized the responses, whereas the inactive enantiomer RP 68,651 had no effect. The apparent efficacy of RP 67580 is somewhat lower than would be expected for the rat NK1 receptor, normally with IC50 values in the 1 nM range (for
review, see Maggi et al., 1993
). The differences in the
present study may reflect the involvement of other tachykinin receptors
in mediation of this response, but the lack of effect of SR48968
excludes a significant NK2 component. The EC50
for SP is also relatively high for a pure NK1 receptor
response, indicating that SP may not be the natural agonist for this
system in this preparation. Interestingly, it was demonstrated in the
perfused rat mesentery that the venoconstriction produced after
electrical stimulation was attenuated by NK1 receptor
antagonism, despite the insensitivity of this preparation to SP (Claing
et al., 1992
). The use of selective NK1 and
NK3 receptor agonists such as septide and senktide would help to determine the exact tachykinin receptor subtypes involved in
mediation of the responses seen in this preparation. Furthermore, the
recent development of NK3 receptor antagonists may also
help to clarify the receptor systems involved.
In contrast to the contractile effect of SP, capsaicin did not cause contraction in unpreconstricted vessels; when vessels were preconstricted to an approximately EC50 level with U-46619, capsaicin relaxed the veins. These observations suggest that, under these experimental conditions, SP was not released in quantities sufficient to alter venous tone. Our functional study demonstrating that neither CGRP nor SP is likely to be involved in the relaxant capsaicin response is consistent with anatomic studies that failed to detect CGRP or SP-like immunoreactivity surrounding small veins. Whereas the anatomic studies have been interpreted as suggesting that there is no sensory innervation of the venous microcirculation, our study clearly demonstrates that the nerves do respond to local sensory stimulation.
Consistent with previous studies (Kim et al., 1995
), removal
of the endothelium abolished the relaxant response to caspsaicin, but
indomethacin given in doses sufficient to inhibit cyclooxygenase had no
effect. The use of NO synthase inhibitors in this system produced
varied responses. L-NMMA (100 µM) had no significant effect on the responses to capsaicin, whereas L-NAME (100 and 300 µM) produced a concentration-dependent rightward shift of the
capsaicin response, suggesting that NO is involved. The apparently increased efficacy of L-NAME over L-NMMA is not
surprising, because it is known that L-NAME is more potent
at inhibiting NO synthase activity than is L-NMMA in
certain systems (e.g., Rees et al., 1990
).
Interestingly, it is also clear that L-NAME shows
approximately 100-fold greater potency against neuronal NO synthase
activity than does L-NMMA (e.g., Salter et
al., 1995
). Confirmation of involvement of some NO was obtained
with the use of the specific guanylate cyclase inhibitor ODQ
(Garthwaite et al., 1995
). The concentration of ODQ used in
these studies was previously shown to inhibit guanylate cyclase; in
this study, confirmation of this effect was obtained because the
relaxation response to the NO donor glyceryl trinitrate was completely
blocked in the presence of ODQ. Our findings are most consistent with
the release of a factor from sensory C-fibers that traverses the thin
wall of the vein to stimulate the endothelium to release NO or an
NO-containing molecule and cause relaxation of vascular smooth muscle
by activating guanylate cyclase. An alternative explanation would be
that the endothelium responds to noxious stimuli and that capsaicin
might activate the endothelium through a mechanism similar to that by which it activates sensory nerves. Although there is evidence for the
presence of sensory neuropeptides within the endothelium (Milner
et al., 1989
), the vanilloid capsaicin receptor has not been
found on cells other than neuronal cells, and studies exploring the
effects of physical or chemical denervation show complete loss of
capsaicin binding in peripheral tissues of rats (Szallasi et
al., 1993
), suggesting that neurons are the sole target for capsaicin.
These studies demonstrate for the first time that capsaicin, an agent known to selectively activate sensory C-fibers, relaxes isolated small veins of rats. The response is endothelium-dependent and appears to be mediated by NO. It is independent of prostanoid generation and is not mediated by CGRP or SP. The existence of a dilator sensory system on the venous side of the microcirculation that responds to the same stimuli as the nerves present on the arterial side suggests that in some situations hydrostatic pressure might not be altered in response to sensory nerve activation. These studies demonstrate the importance of examining the reactivity of both sides of the microcirculation individually, and they provide insight into the mechanisms of the diverse (pro- or anti-inflammatory) effects of activation of C-fibers seen in vivo.
| |
Footnotes |
|---|
Accepted for publication December 6, 1996.
Received for publication April 18, 1996.
1 This work and A.A. were supported by The Wellcome Trust.
Send reprint requests to: Dr. Amrita Ahluwalia, Centre for Clinical Pharmacology, The Rayne Institute, University College London, 5 University St., London WC1E 6JJ, UK.
| |
Abbreviations |
|---|
CGRP, calcitonin gene-related peptide;
L-NAME, N
-nitro-L-arginine methyl
ester;
NK, neurokinin;
L-NMMA, NG-monomethyl-L-arginine;
NO, nitric oxide;
ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one;
SP, substance P.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. S. Scotland, S. Chauhan, C. Davis, C. De Felipe, S. Hunt, J. Kabir, P. Kotsonis, U. Oh, and A. Ahluwalia Vanilloid Receptor TRPV1, Sensory C-Fibers, and Vascular Autoregulation: A Novel Mechanism Involved in Myogenic Constriction Circ. Res., November 12, 2004; 95(10): 1027 - 1034. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||